Why is "Neuropsychiatry" trending?

Search Interest Perspective

• Closing the gap in pediatric neuropsychiatry: Kennedy Krieger doctors release second edition textbook - EurekAlert!
• Congyu Liao Takes a Physics First Approach to Advancing Neuropsychiatry - UCSF Radiology
• Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals (NASDAQ: NRXP), Alleging Breach of Contract and Misrepresentation in Connection with Acquisition - Yahoo Finance
• Redox therapy for neuropsychiatric disorders: Molecular mechanisms and biomarker development - Science | AAAS
• A new hope: locus coeruleus-norepinephrine system at the nexus of neuropsychiatric symptoms - Nature
• Tetrabenazine and Suicidal Ideation - Psychiatry Online
• Neuropsychiatric Features in Patients With Idiopathic Normal Pressure Hydrocephalus - Neurology® Journals
• Pediatric Neuropsychiatry: A Case-Based Approach (IMAGE) - EurekAlert!
• Neuropsychiatry on screen - The Lancet
• Stuttering, A Misunderstood Condition: What the Field of Neuropsychiatry Can Do to Help - Psychiatric Times
• CMSC 2026: Neuropsychiatric care in MS has seen major progress - Multiple Sclerosis News Today
• Narrative Review of Body-First Versus Brain-First Prodromal Neuropsychiatric Symptoms in Parkinson’s Disease - Cureus
• Neuropsychiatry Research Roundup - UCSF Radiology
• Cell-type-specific genetic architecture reveals neuronal and immune contributions to neuropsychiatric disorders - Nature
• In Memoriam: Robert G. Robinson, M.D., F.A.N.P.A. - Psychiatry Online
• For the first time, Robert A. Winn Career Development Award opens to neuropsychiatry investigator-physicians - EurekAlert!
• Influenza-Induced Mania - Psychiatry Online
• The role of brain health and resilience in reshaping trajectories of late-life neuropsychiatric disorders - Nature
• Amisulpride-Induced Macrocytic Anemia - Psychiatry Online
• Numbers Written Counterclockwise in the Clock Drawing Test - Psychiatry Online
• Neuropsychiatric Disorders and Treatment Market Report 2035 - Market Research Future
• Cantex and Headlamp Health Forge Strategic Partnership to Accelerate Azeliragon Development via Agentic Precision Neuropsychiatry for Severe Depression and Fatigue in Patients with Multiple Sclerosis - PR Newswire
• Association between anosognosia and neuropsychiatric symptoms in Alzheimer’s disease dementia patients - Nature
• Integrating neuropsychoanalytic and neuropsychiatric perspectives into psychiatric clinical neuroscience curricula: A conceptual overview - Frontiers
• AI-Driven Biomarker Discovery from Wearables in Neuropsychiatric Research - Psychiatric Times
• Editorial: The role of epigenetics in neuropsychiatric disorders - Frontiers
• Advancements in understanding neuropsychiatric lupus: deciphering immune heterogeneity with single-cell resolution - Frontiers
• The Role of MicroRNAs as Biomarkers in Neuropsychiatric Disorders - Psychiatrist.com
• In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuum | Molecular Psychiatry - Nature
• The relationship between neuropsychiatric dimensions and markers of Parkinson’s disease risk in the UK Biobank - Nature
• Johnson & Johnson reinforces its leadership in advancing neuropsychiatry with new portfolio and pipeline data at APA and ASCP - Investing News Network
• The gut–brain axis in pharmacology: microbiome-driven modulation of CNS drugs and neuropsychiatric outcomes - Frontiers
• Prevalence of neurodivergence in neuropsychiatric conditions: cross-sectional study - Cambridge University Press & Assessment
• T cell activation reveals immune-mediated mechanisms and drug targets for neuropsychiatric disorders - Nature
• Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients - BioSpace
• UBC Medicine’s Dr. Trevor Hurwitz, founder of neuropsychiatry in B.C., appointed to the Order of Canada - UBC Faculty of Medicine
• Trapped inside the 'scariest place' — a psychiatric hospital in Indiana - WFYI
• Draig Therapeutics Closes Oversubscribed $65 Million Series B to Accelerate Development of Highly Specific AMPA and GABAA Receptor Modulators in Neuropsychiatric Disorders - Business Wire
• David Dosa and Andrew Tapper named to newly established endowed chairs - UMass Chan Medical School
• Recognizing the Neuropsychiatric Symptoms of Huntington Disease - Psychiatric Times
• Syremis Therapeutics Names Neuropsychiatry Veteran Dr. Aaron Koenig Chief Medical Officer - citybiz
• Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals - TradingView
• Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones - Business Wire
• Exploring Metabolic Neuropsychiatry with Professor Anthony Vernon - kcl.ac.uk
• Neurocrine Biosciences Appoints Mike Sibley as Senior Vice President, General Manager of Neuropsychiatry Franchise - PR Newswire
• David Okai: My Working Life as a Consultant Neuropsychiatrist - The BMJ
• Mild Behavioral Impairment: A Population-Based Study - Psychiatry Online
• Neuropsychiatric symptom subtypes and dementia‐associated neuropathologic change - Wiley & Sons
• Why does FND mainly affect women? A consideration of gender imbalance in neuropsychiatric disease - Cambridge University Press & Assessment
• Plasma p-tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic - Wiley & Sons
• The association between anosognosia and neuropsychiatric symptoms in neurodegenerative dementias: a narrative review - Frontiers
• Practical Strategies to Optimize Iron Supplementation From an Expert in Neuropsychiatry - Physician's Weekly
• Why neuropsychiatry faces training challenges - the limbic
• Reigniting Innovation in Neuropsychiatry - Bristol Myers Squibb
• A practical guide to sequencing in neuropsychiatric research - Nature
• Breakthrough Discovery Reveals How Connection Between Mitochondrial Vulnerability and Neurovasculature Function Impacts Neuropsychiatric Disease - Children's Hospital of Philadelphia
• Johnson & Johnson to present new portfolio and pipline data at APA and ASCP - Manufacturing Chemist
• Gedeon Richter UK takes over UK rights to cariprazine - PharmaTimes
• Neuropsychiatry/TBI Unit at Walter Reed unique in DoD - Walter Reed National Military Medical Center (.mil)
• Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases - Psychiatric Times
• Child Neuropsychiatry at the Microcitemico Hospital, a letter to Todde: "A place unworthy of a civilized country." - L'Unione Sarda.it
• Cognitive Neuropsychiatry: - Psychiatry Online
• A framework for the investigation of rare genetic disorders in neuropsychiatry - Nature
• Dangers of self-diagnosis in neuropsychiatry | Psychological Medicine - Cambridge University Press & Assessment
• Breaking Down Binary Thinking in Neuropsychiatry | The Journal of Neuropsychiatry and Clinical Neurosciences - Psychiatry Online
• Flu, Not Antiviral, May Cause Neuropsychiatric Risk in Kids - Medscape
• Tourette's And OCD Overlap, And a Newly Discovered Brain Link May Explain Why - ScienceAlert
• Event marks contributions of world-renowned neuropsychiatric genetics researchers - Cardiff University
• J&J presents neuropsychiatry data at APA and ASCP meetings By Investing.com - Investing.com Canada
• Huntington Disease: Recognizing Neuropsychiatric Symptoms - Psychiatric Times
• LBRX IPO News - Neuropsychiatry biotech LB Pharmaceuticals files for a $100 million IPO - renaissancecapital.com
• LBRX IPO News - Neuropsychiatry biotech LB Pharmaceuticals sets terms for $250 million IPO - renaissancecapital.com
• Neuropsychiatry of Catatonia: Clinical Implications - Psychiatric Times
• PANS AND PANDAS - Göteborgs universitet
• Risk of neuropsychiatric and related conditions associated with SARS-CoV-2 infection: a difference-in-differences analysis - Nature
• The spectrum of psychosis in people with neurological disease - Cambridge University Press & Assessment
• Bidirectional crosstalk between the gut microbiota and cellular compartments of brain: Implications for neurodevelopmental and neuropsychiatric disorders - Nature
• Neuropsychiatry revisited: epilepsy as the borderland between neurology and psychiatry - Frontiers
• Syremis Therapeutics Adds Aaron Koenig as Chief Medical Officer - Contract Pharma
• Brain–computer interfaces for neuropsychiatric disorders - Nature
• Mitochondrial dysfunction in the blood-brain barrier may contribute to neuropsychiatric disease in 22qDS - News-Medical
• Lysosomal Diseases and Neuropsychiatry: Opportunities to Rebalance the Mind - Frontiers
• Brain age and other bodily ‘ages’: implications for neuropsychiatry - Molecular Psychiatry - Nature
• Six Landmark Case Reports Essential for Neuropsychiatric Literacy - Psychiatry Online
• Neuropsychiatry: Bringing a Precision Approach to the Treatment of Brain Disease - Mass General Giving
• American Neuropsychiatric Association 2024 Annual Meeting Abstracts - Psychiatry Online
• Impact of Nitrous Oxide on Neuropsychiatric Impairment in Adolescents: A Scoping Review - Cureus
• Newleos Therapeutics Announces Clinical Progress Across Neuropsychiatric Pipeline - Business Wire
• Cold-Water Immersion: Neurohormesis and Possible Implications for Clinical Neurosciences - Psychiatry Online
• ACS Neuropsychiatry helps aviators keep head in the game, stay in the fight - wpafb.af.mil
• A Critical Catch: Catatonia Due to Multiple General Medical Conditions - Psychiatric Times
• Catatonia: State-of-the-Science Advances in the Journal of Neuropsychiatry and Clinical Neurosciences - Psychiatry Online
• A national survey of neuropsychiatry training experiences - Cambridge University Press & Assessment
• The Microbiota‐Gut‐Brain Connection: A New Horizon in Neurological and Neuropsychiatric Disorders - Wiley Online Library
• Father of Developmental Neuropsychiatry - Johns Hopkins Medicine
• The Population-Based Incidence and Prevalence of Catatonia - Psychiatry Online
• What's New in Neuropsychiatry - Psychiatry Online
• Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: A Comprehensive Review - Rheumatology Advisor
• The might of light for revealing neuropsychiatric mechanisms - Neuropsychopharmacology - Nature
• Methylphenidate Improves HIV-1–Associated Cognitive Slowing - Psychiatry Online